Skip to main content
ImmuneCited

When Is It Appropriate to Use Arginine in Critical Illness?

Jayshil J Patel, Keith R Miller, Cameron Rosenthal, Martin D Rosenthal
Review Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2016 42 件の引用
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D27252277'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

研究タイプ
Review
対象集団
Critically ill patients (arginine use)
介入
When Is It Appropriate to Use Arginine in Critical Illness? None
比較対照
None
主要アウトカム
None
効果の方向
Mixed
バイアスリスク
Unclear

Abstract

In health, arginine is considered a nonessential amino acid but can become an essential amino acid (ie, conditionally essential amino acid) during periods of metabolic or traumatic stress as endogenous arginine supply is inadequate to meet physiologic demands. Arginine depletion in critical illness is associated with impairments in microcirculatory blood flow, impaired wound healing, and T-cell dysfunction. The purpose of this review is to (1) describe arginine metabolism and role in health and critical illness, (2) describe the relationship between arginine and asymmetric dimethylarginine, and (3) review studies of supplemental arginine in critically ill patients.

要約

The relationship between arginine and asymmetric dimethylarginine is described and the role in health and critical illness is described, and studies of supplementalArginine in critically ill patients are reviewed.

Used In Evidence Reviews

Similar Papers